Addressing the challenges of polygenic scores in human genetic research
- PMID: 36459976
- PMCID: PMC9808501
- DOI: 10.1016/j.ajhg.2022.10.012
Addressing the challenges of polygenic scores in human genetic research
Abstract
The genotyping of millions of human samples has made it possible to evaluate variants across the human genome for their possible association with risks for numerous diseases and other traits by using genome-wide association studies (GWASs). The associations between phenotype and genotype found in GWASs make possible the construction of polygenic scores (PGSs), which aim to predict a trait or disease outcome in an individual on the basis of their genotype (in the disease case, the term polygenic risk score [PRS] is often used). PGSs have shown promise for studying the biology of complex traits and as a tool for evaluating individual disease risks in clinical settings. Although the quantity and quality of data to compute PGSs are increasing, challenges remain in the technical aspects of developing PGSs and in the ethical and social issues that might arise from their use. This ASHG Guidance emphasizes three major themes for researchers working with or interested in the application of PGSs in their own research: (1) developing diverse research cohorts; (2) fostering robustness in the development, application, and interpretation of PGSs; and (3) improving the communication of PGS results and their implications to broad audiences.
Copyright © 2022. Published by Elsevier Inc.
References
-
- McCarthy M., Birney E. Personalized profiles for disease risk must capture all facets of health. Nature. 2021;597:175–177. - PubMed
-
- Polygenic Risk Score Task Force of the International Common Disease Alliance Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat. Med. 2021;27:1876–1884. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
